Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $157B | +$1.31B | 263 | 3.57% | Increased |
|
| 2 |
BlackRock
New York
| $148B | +$2.55B | 283 | 3.77% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $89.6B | +$2.39B | 263 | 4.25% | Increased |
|
| 4 |
Wellington Management Group
Boston,
Massachusetts
| $38.8B | -$101M | 83 | 6.21% | Reduced |
|
| 5 |
Geode Capital Management
Boston,
Massachusetts
| $32B | +$1.19B | 290 | 3.86% | Increased |
|
| 6 |
Fidelity Investments
Boston,
Massachusetts
| $30.7B | -$1.68B | 173 | 2.27% | Reduced |
|
| 7 |
JP Morgan Chase
New York
| $27.6B | +$1.47B | 233 | 3.19% | Increased |
|
| 8 |
T. Rowe Price Associates
Baltimore,
Maryland
| $26.3B | +$113M | 134 | 2.36% | Increased |
|
| 9 |
Capital World Investors
Los Angeles,
California
| $25.7B | -$452M | 26 | 4.07% | Reduced |
|
| 10 |
Northern Trust
Chicago,
Illinois
| $22.8B | -$224M | 255 | 3.73% | Reduced |
|
| 11 |
Bank of America
Charlotte,
North Carolina
| $21B | -$615M | 273 | 2.03% | Reduced |
|
| 12 |
Morgan Stanley
New York
| $20.2B | +$560M | 309 | 2.49% | Increased |
|
| 13 |
Bank of New York Mellon
New York
| $19.5B | -$171M | 215 | 3.52% | Reduced |
|
| 14 |
Norges Bank
Oslo,
Norway
| $18.4B | -$251M | 76 | 3.78% | Reduced |
|
| 15 |
Capital International Investors
Los Angeles,
California
| $17.7B | -$1.47B | 24 | 3.74% | Reduced |
|
| 16 |
Capital Research Global Investors
Los Angeles,
California
| $16.7B | -$1.5B | 10 | 3.69% | Reduced |
|
| 17 |
Franklin Resources
San Mateo,
California
| $16B | -$58.8M | 84 | 5.76% | Reduced |
|
| 18 |
Charles Schwab
San Francisco,
California
| $14.5B | +$395M | 185 | 4.28% | Increased |
|
| 19 |
BBA
Baker Bros. Advisors
New York
| $14.1B | +$120M | 46 | 68.72% | Increased |
|
| 20 |
Primecap Management
Pasadena,
California
| $12.8B | -$154M | 19 | 8.85% | Reduced |
|
| 21 |
Legal & General Group
London,
United Kingdom
| $12.4B | -$39.2M | 187 | 3.75% | Reduced |
|
| 22 |
Dodge & Cox
San Francisco,
California
| $12.3B | +$43.1M | 12 | 7.59% | Increased |
|
| 23 |
Invesco
Atlanta,
Georgia
| $11.9B | +$633M | 135 | 2.86% | Increased |
|
| 24 |
Ameriprise
Minneapolis,
Minnesota
| $11.7B | +$942M | 92 | 3.25% | Increased |
|
| 25 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $11.4B | +$159M | 183 | 5.15% | Increased |
|